PD‐L1 and PD‐L2 expression status in relation to chemotherapy in primary and metastatic esophageal squamous cell carcinoma

Immune checkpoint inhibitors have shown efficacy in various cancers. Although programmed death ligand 1/2 (PD‐L1/L2) expressions have been demonstrated as predictive biomarkers of response to immune checkpoint inhibitors and prognostic markers, whether PD‐L1/L2 expression is altered in esophageal sq...

Descripción completa

Detalles Bibliográficos
Autores principales: Okadome, Kazuo, Baba, Yoshifumi, Yasuda‐Yoshihara, Noriko, Nomoto, Daichi, Yagi, Taisuke, Toihata, Tasuku, Ogawa, Katsuhiro, Sawayama, Hiroshi, Ishimoto, Takatsugu, Iwatsuki, Masaaki, Iwagami, Shiro, Miyamoto, Yuji, Yoshida, Naoya, Watanabe, Masayuki, Komohara, Yoshihiro, Baba, Hideo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819296/
https://www.ncbi.nlm.nih.gov/pubmed/34773342
http://dx.doi.org/10.1111/cas.15198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819296/
https://www.ncbi.nlm.nih.gov/pubmed/34773342
http://dx.doi.org/10.1111/cas.15198

Ejemplares similares